媒体报道
2019 年 08 月 06 日
Dr Qian, Transcenta was established in January 2019 from the merger of two biotech companies: your company, MabSpace Biosciences and HJB, founded by Jonathan Zhao. What brought both companies together?
There were a number of reasons for the merger. Ultimately, there needed to be a common value proposition for us to work together. Jonathan and I actually worked together at Amgen, one of the world’s leading biotech companies. We both understand the necessary elements for developing, producing and commercializing a biotherapeutic drug, so we share the same value and standards, and knew we could work well together...